As Kingsley Chiedu Moghalu marks his 63rd birthday, his life’s journey stands as a compelling story of intellect, discipline, and transformative leadership. From the corridors of the United Nations to ...

Merck and Terns Pharmaceuticals have agreed to a $6.7 billion all-cash buyout that delivers a prized leukemia asset to the New Jersey Big Pharma. The crown jewel of the deal is TERN-701, an oral ...

Lead CML researcher discusses the evolution of a groundbreaking treatment and its effect on patient survival. When imatinib (Gleevec; Novartis), the first-ever tyrosine kinase inhibitor, made its ...

What is chronic myeloid leukaemia (CML)? Chronic myeloid leukaemia (CML) is a type of cancer that affects the blood and bone marrow. It usually develops very slowly. Symptoms of chronic myeloid ...

The survival prognosis for patients with chronic phase CML has greatly improved since the introduction of TKIs, with some studies showing life expectancy close to the general population. Nonetheless, ...

Chemotherapy uses anti-cancer (cytotoxic) drugs to destroy or damage leukaemia cells. It works by disrupting the way leukaemia cells grow and divide. Most people with chronic myeloid leukaemia (CML) ...

US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available ...

In an interview with Targeted Oncology, Michael Mauro, MD, delved into the rapidly advancing field of chronic myeloid leukemia treatment. With treatments for chronic myeloid leukemia (CML) evolving, ...

Novartis has picked up a new FDA approval for its chronic myeloid leukaemia therapy Scemblix that it believes is critical to unlocking the drug's blockbuster sales potential. First-in-class STAMP ...

Sunrise presenter Edwina Bartholomew announced in a live segment on Friday morning that she has cancer. Bartholomew's chronic myeloid leukaemia (CML) was first diagnosed in July and she will be ...

Chronic myelogenous leukemia (CML) is a cancer that affects your blood cells and bone marrow -- the soft part inside your bones where blood cells are made. You may also hear your doctor call it ...